bisphosphonate aSMase inhibitors (Humboldt University of Berlin/RWTH)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebisphosphonate aSMase inhibitors (Humboldt University of Berlin/RWTH)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingomyelin phosphodiesterase inhibitors
TargetsSphingomyelin phosphodiesterase
Therapy Area/IndicationsAtherosclerosisPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHumboldt-Universitaet Zu Berlin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companiesipal GmbHRheinisch-Westfaelische Technische Hochschule Aachen UniversityHumboldt-Universitaet Zu Berlin
Active IndicationsN/A
Inactive IndicationsAtherosclerosisPneumonia

Other Information

ATC CodeN/A
Related LinksN/A